semaglutide for cholesterol Ozempic and Wegovy ingredient may reverse signs of liver disease Attainment of standard (HbA1c |

Standards of medical care in diabetes 2017

It was approved in the UK in 2023 for weight management in adults with: BMI 30 kg/m (obesity), or BMI 27 kg/m (overweight) with at least one weight-related condition The medication works in several ways: Reduces hunger signals by acting on the brains appetite control centre Slows stomach emptying , creating longer-lasting fullness after meals Reduces food cravings , particularly for ultra-processed foods Clinical trials show that people taking Wegovy lose an average of 15% of their body weight after 68 weeks, compared to 2.4% with placebo

A deficiency in Vitamin B12 can lead to fatigue, weakness, and even neurological complications

The fatigue phase sucked

Brand name for weight loss: Tirzepatide is approved for weight loss under the brand name Zepbound